Monoclonal antibodies have revolutionized the biotechnology industry with their potential to cure chronic diseases such as cancers and autoimmune disorders. These are laboratory-produced molecules engineered to serve as human antibodies that can restore, enhance or mimic the immune system's attack on unhealthy cells. The targeted monoclonal antibody therapeutics market helps fight cancer, inflammation, immune-mediated illnesses and infections.
The global Monoclonal ... Read more
